Skip to main content

Advertisement

Log in

Antimuscarinic therapy in men with bladder outlet obstruction

  • Clinical Trials Report
  • Published:
Current Urology Reports Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References and Recommended Reading

  1. Abrams P, Kaplan S, De Koning Gans HJ, Millard R: Safety and tolerability of tolterodine for the treatment of overactive bladder in men with bladder outlet obstruction. JUrol 2006, 175:999–1004.

    CAS  Google Scholar 

  2. Macdiarmid S, Chen A, Tu N, Aquilina J, Peters K: Effects of tamsulosin and extended-release oxybutynin on lower urinary tract symptoms in men [abstract 1639]. J Urol 2006, 175(Suppl 4):1–554.

    Google Scholar 

  3. Jacobsen SJ, Jacobson DJ, Girman CJ, et al.: Treatment for benign prostatic hyperplasia among community dwelling Men: the Olmsted County study of urinary symptoms and health status. J Urol 1999, 162:1301–1306.

    Article  PubMed  CAS  Google Scholar 

  4. Roehrborn CG, McConnell JD, Saltzman B, et al.: Storage (irritative) and voiding (obstructive) symptoms as predictors of benign prostatic hyperplasia progression and related outcomes. Eur Urol 2002, 42:1–6.

    Article  PubMed  Google Scholar 

Download references

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Staskin, D.R., Kaplan, S.A. & Wein, A.J. Antimuscarinic therapy in men with bladder outlet obstruction. Curr Urol Rep 7, 437–439 (2006). https://doi.org/10.1007/s11934-006-0050-9

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11934-006-0050-9

Keywords

Navigation